But it also has been shown that ERα-positive breast cancer cells can secrete FGFR and EGFR ligands in response to estrogen, which can act as paracrine mediators to promote CSC activity and expand the fraction of CD44+ CD24−/lo cells [41, 42]. This evidence concerns the gene CD44 and breast carcinoma.